Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Other Non-Current Assets: 2015-2024

Historic Other Non-Current Assets for Editas Medicine (EDIT) over the last 10 years, with Dec 2024 value amounting to $5.2 million.

  • Editas Medicine's Other Non-Current Assets fell 43.38% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 43.38%. This contributed to the annual value of $5.2 million for FY2024, which is 39.18% down from last year.
  • Editas Medicine's Other Non-Current Assets amounted to $5.2 million in FY2024, which was down 39.18% from $8.6 million recorded in FY2023.
  • Editas Medicine's 5-year Other Non-Current Assets high stood at $8.6 million for FY2023, and its period low was $4.7 million during FY2020.
  • In the last 3 years, Editas Medicine's Other Non-Current Assets had a median value of $5.3 million in 2022 and averaged $6.4 million.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first skyrocketed by 63.49% in 2023, then plummeted by 39.18% in 2024.
  • Editas Medicine's Other Non-Current Assets (Yearly) stood at $4.7 million in 2020, then skyrocketed by 44.82% to $6.8 million in 2021, then decreased by 22.87% to $5.3 million in 2022, then spiked by 63.49% to $8.6 million in 2023, then crashed by 39.18% to $5.2 million in 2024.